- Recommendation ID
- NG217/01
- Question
Antibody testing: What immunomodulation strategies are effective in people with defined autoimmune epilepsy syndromes?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation for research, see the rationale section on antibody testing.
Full details of the evidence and the committee's discussion are in evidence review D: antibody testing in epilepsy.
Source guidance details
- Comes from guidance
- Epilepsies in children, young people and adults
- Number
- NG217
- Date issued
- April 2022
Other details
Is this a recommendation for the use of a technology only in the context of research? | No |
Is it a recommendation that suggests collection of data or the establishment of a register? | No |
Last Reviewed | 30/04/2022 |